Renal Replacement Therapy

Editor's selection: 2015 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease

Renal anemia is a complication of chronic kidney disease. Guidelines for safe and effective treatment in patients with renal anemia are needed. Therefore, the Executive Board of the Japanese Society for Dialysis Therapy (JSDT) decided that it was time to revise the guidelines to make them more appropriate to the situation of chronic kidney disease patients in Japan. This is the third edition of the guidelines for renal anemia published by the JSDT. The purpose is to improve the prognosis of chronic kidney disease patients, including after renal transplantation, through the treatment of renal anemia. The intended users of the guidelines are all healthcare professionals engaged in the treatment of chronic kidney disease.

Editor's selection: Current status of kidney transplantation in Japan in 2015: the data of the Kidney Transplant Registry Committee, Japanese Society for Clinical Renal Transplantation and the Japan Society for Transplantation

The first deceased and living donor kidney transplants were performed in 1956 and 1964 in Japan, respectively. Larger numbers of transplants were performed after the introduction of cyclosporine in 1983. After that, the number has gradually and steadily increased and 1661 transplants were performed in 2015. In addition, the outcomes have improved year by year. The indications for transplantation have also expanded in various aspects, such as recipient and donor age, primary diseases, ABO incompatible and highly sensitized cases, and preemptive transplant.

We here report the current status of kidney transplantation in Japan. The number of transplants, detail transplant characteristics in the past decade, and outcomes are described.

Recent
Most accessed

Upcoming conferences

The 62nd Annual Meeting of the Japanese Society for Dialysis Therapy
15 - 18 June 2017, Pacifico Yokohama

The 63rd Annual Meeting of the Japanese Society for Dialysis Therapy
28 June - 1 July 2018, Kobe International Conference Center

The 64th Annual Meeting of the Japanese Society for Dialysis Therapy
27 - 30 June 2019, Pacifico Yokohama

ISN Frontiers Meeting : Kidney Disease and Cardiovascular Disease
22-25 February 2018, Tokyo, KEIO Plaza Hotel

The 51st Annual Meeting of the Japanese Society for Clinical Renal Transplantation
14 - 16 February 2018, Kobe Fashion Mart Event Floor

The 23rd Annual Meeting of the Japanese Society for Peritoneal Dialysis
7 - 8 October 2017, Kitakyushu International Conference Center

The 24th Annual Meeting of the Japanese Society for Peritoneal Dialysis
6 - 7 October 2018, Toshi Center Hotel Tokyo

The 28th Annual Meeting of the Japan Society for Blood Purification Critical Care
22 - 24 September 2017, Hotel Rafre Saitama

The 29th Annual Meeting of the Japan Society for Blood Purification Critical Care
18 - 20 October 2018, WINC Aichi

Submit your manuscript

Renal Replacement Therapy is now accepting submissions; please use the online submission system to submit your manuscript. For all enquiries about the journal, please contact: rrtjournal@biomedcentral.com.

Aims and scope

Renal Replacement Therapy is a peer-reviewed journal facilitating worldwide discussion of research and issues related to the study of renal replacement therapy.

RRT considers articles on all aspects of hemodialysis, peritoneal dialysis, blood purification, renal transplantation and regenerative medicine. In addition, the journal publishes content in wider fields such as chronic kidney disease (CKD), acute kidney injury (AKI), critical care medicine and intensive care, bone and mineral metabolism, anemia and iron metabolism, infection, cardiac disease, cerebral disease, diabetes mellitus, hypertension, nutrition, and related social issues. Contributions are encouraged from a global perspective across many disciplines.

Society affiliations

Renal Replacement Therapy is the official publication of the following societies:

Japanese Society for Dialysis Therapy (JSDT)

Founded in 1968, the JSDT has over 16,000 members and is one of the largest societies in Japan. The JSDT promote advances in technology, research and the dissemination of knowledge related to renal replacement medicine. Japan remains a leader in renal replacement therapy including dialysis therapy, and the JSDT play a significant role in proposing clinical guidelines to improve the life prognosis and QOL of CKD patients.

Japanese Society for Clinical Renal Transplantation (JSCRT)

The Japanese Society for Clinical Renal Transplantation (JSCRT) was founded in 1969 on the vision of promoting the advancement of the science and practice of renal transplantation. JSCRT has expanded to include nearly 1,500 renal transplant professionals, including surgeons, physicians, pediatrician, nurses, coordinators, social workers, pharmacists, and dieticians. JSCRT is also dedicated to educating renal transplant professionals, to promoting research, and to advocating the highest quality care for patients.

Japanese Society for Peritoneal Dialysis (JSPD)

The Japanese Society for Peritoneal Dialysis (JSPD) aims to contribute to the advancement of medicine and medical practice, the development of academic culture and people’s welfare through implementing programs for advancement, development and propagation of medical practice and research regarding renal failure and peritoneal dialysis therapies for people all over Japan. JSPD was established in 1995, and has currently 1,500 members.

Japan Society for Blood Purification in Critical Care (JSBPCC)

The Japan Society for Blood Purification in Critical Care was founded in 1990 and aims to further the development and establishment of acute blood purification, such as continuous renal replacement therapy (CRRT). JSBPCC comprises nephrologists, emergency/critical care physicians, as well as clinical engineers and nurses mainly working in intensive care units (ICU). JSBPCC is dedicated to the development of safe and effective blood purification therapy for saving the lives of critically ill patients.

About the Editor

Prof Takashi Shigematsu, Editor-in-Chief

Prof Shigematsu is currently Professor and Director of the Division of Nephrology, Department of Internal Medicine at the Wakayama Medical University School of Medicine, Japan. He is also Director of Blood purification Medicine, and Clinical Engineering at Wakayama Medical University Hospital, as well as a member of the International Society of Nephrology and the American Society of Nephrology.

His research interests focus on bone and mineral metabolism within chronic kidney disease (CKD). In addition, he has been investigating and working in fields of hemodialysis, peritoneal dialysis, blood purification medicine in acute kidney injury, kidney transplantation.